ASX Company Announcements


The edited text of our announcements are sourced from the Australian Stock Exchange and are delayed by at least 20 minutes. Retrieving the edited text of a company announcement indicates your acceptance of the Conditions.

Cellmid does not take any responsibility in respect of any of the edited text sourced from the Australian Stock Exchange.


 28 Dec 2012

 Change in Director's Interest - M Rogers

 14 Dec 2012

 Change in Director's Interest - M Halasz

 04 Dec 2012

 Change in Director's Interest - M Rogers

 04 Dec 2012

 Change in Director's Interest - M Halasz

 23 Nov 2012

 Result of Meeting

 23 Nov 2012

 AGM presentation

 20 Nov 2012

 Investor Presentation

 09 Nov 2012

 Change in Director's Interest - M Rogers

 07 Nov 2012

 Change in Director's Interest - D King

 07 Nov 2012

 Change in Director's Interest - M Halasz

 29 Oct 2012

 Amended Top 20 Option Holders

 29 Oct 2012

 Dispatch of Options Entitlements Offer Holding Statements

 24 Oct 2012

 $545K Options Rights Issue Completed

 24 Oct 2012

 Annual Report to Shareholders

 24 Oct 2012

 Notice of Annual General Meeting and Proxy Form

 22 Oct 2012

 Appendix 4C - quarterly

 02 Oct 2012

 Change in Director's Interest - M Halasz

 02 Oct 2012

 $748K R&D Tax Credit Received

 20 Sep 2012

 Initial Director's Interest Notice - M Rogers

 19 Sep 2012

 Appointment of Director

 14 Sep 2012

 Underwritten Non-Renounceable Pro-Rata Offer and Placement of Options

 13 Sep 2012

 évolis® Hair Growth Products Exceed Distribution Targets

 04 Sep 2012

 Exclusive Distributor Appointed for évolis®

 30 Aug 2012

 Appendix 4E and Preliminary Final Report

 28 Aug 2012

 Initial Director's Interest - G Kaufman

 27 Aug 2012

 Appointment and Resignation of Directors

 21 Aug 2012

 Appendix 3B

 06 Aug 2012

 Appointment of Joint Company Secretary

 30 Jul 2012

 Cellmid News

 27 Jul 2012

 Appendix 3B

 26 Jul 2012

 Midkine Ischemia Patent Allowed in US

 23 Jul 2012

 Appendix 4C

 12 Jul 2012

 Change of Director's Interest Notice - M Halasz

 25 Jun 2012

 2nd Midkine Conference

 20 Jun 2012

 Appendix 3B

 07 Jun 2012

 Appendix 3B

 30 May 2012

 évolis to be sold at Terry White

 28 May 2012

 Results of Meeting

 25 May 2012

 Change in substantial holding

 11 May 2012

 Ceasing to be a substantial holder

 07 May 2012

 Appendix 3B

 07 May 2012

 Treg Antibody Patent Allowed in USA

 30 Apr 2012

 Notice of Extraordinary General Meeting / Proxy Form

 26 Apr 2012

 Appendix 4C

 24 Apr 2012

 Cellmid Completes $1.5M Placement

 20 Apr 2012

 Final Share Issue to La Jolla Cove - Appendix 3B

 19 Apr 2012

 Commercial website launched for évolis™

 18 Apr 2012

 USA Antibody Patent for Adhesion Allowed

 16 Apr 2012

 Appendix 3B

 04 Apr 2012

 Appendix 3B

 03 Apr 2012

 Change of Director's Interest Notice - R Beaumont

 29 Mar 2012

 Appendix 3B

 29 Mar 2012

 Media Launch of évolis™ Hair Products

 16 Mar 2012

 Appendix 3B

 13 Mar 2012

 Change of Director's Interest Notice - M Halasz

 06 Mar 2012

 Appendix 3B

 05 Mar 2012

 Annual Report on Celera (Quest) License

 28 Feb 2012

 Appendix 4D and Half Year Accounts

 28 Feb 2012

 Appendix 3B

 20 Feb 2012

 Appendix 3B

 20 Feb 2012

 Notice of Change of Interest of Substantial Holder

 15 Feb 2012

 TGA Registration and Launch of Cellmid's évolis™ Products

 13 Feb 2012

 La Jolla Funding Agreement Termination

 30 Jan 2012

 Appendix 4C

 24 Jan 2012

 Appendix 3B